Aethlon CEO Discusses "First-In-Man" HIV Study On CEOcast
Aethlon Medical, Inc. (OTCBB:AEMD) disclosed this evening that its CEO, James A. Joyce, is currently featured in an on-line interview with CEOcast, Inc. During the interview, Mr. Joyce discusses the "first-in-man" clinical study of the Aethlon Hemopurifier® as a treatment for HIV/AIDS.
The historic takeover of Fannie Mae and Freddie Mac, which could come as soon as this weekend, moved to the forefront of the presidential campaign Saturday.
In the arena that night, the whole last minute was drowned out by cheers — and then when the soaring music swelled, the confetti rained down as the harbinger of balloons and the hopeful first family took the stage, forget about it — it was a perfect end to a convention that last Monday, no one even knew if it would happen. But it did, and I'm so glad to have been there.
